CLF Surges After Q3 Print as Analysts Race to Catch Up

Cleveland-Cliffs posted a 12.6% jump on earnings day, and two days later the Street is still revising targets higher while short sellers quietly add to already-elevated positions.

The analyst reaction has been the most visible story since the Q3 release. Wells Fargo's Timna Tanners lifted her target from $14 to $17 on October 20, keeping an Overweight rating, while Morgan Stanley raised to $14 from $12.50, holding Equal-Weight. Barclays moved the opposite direction on conviction, keeping an Underweight but nudging its target to $11 from $10. JP Morgan, which cut its target to $12 from $13 earlier this month, now looks notably below the pack. The mean price target across the Street has settled at $13.95, essentially in line with the current price of $13.65, leaving almost no implied upside in the consensus. Factor scores reflect this ambivalence: the analyst recommendation divergence ranks in the 94th percentile of the universe, meaning the gap between bulls and bears is wider than almost any other name, and EPS surprise scores in the 72nd percentile, pointing to a track record of beating estimates even as the fundamental picture remains contested. Valuation multiples are moving fast. The EV/EBITDA has dropped 2.0 points over the past 30 days to 5.65x, a meaningful compression that suggests the market is paying less per unit of operating earnings than it was a month ago, even after the post-earnings bounce.

Short interest tells a story that cuts against the bullish price action. Bears hold 12.5% of the free float, marginally higher than the 12.2% flagged in Monday's earnings preview, and the position has grown roughly 2.2% over the past week. That is not a dramatic squeeze, but it is notable that shorts are adding rather than covering after a 12.6% single-day move. The borrow market offers some explanation for the persistence: availability is running at 645%, meaning for every share already shorted there are roughly six and a half more available in the lending pool, so new short positions face no friction. Cost to borrow has jumped 63% week-on-week to 0.56%, its highest level in about a month, but in absolute terms it remains trivially cheap. The ORTEX short score has edged up to 55.95, its highest reading in the 10-day window shown, consistent with a position that is gently rebuilding rather than unraveling. Options positioning leans in the other direction: the put/call ratio has dropped to 0.47, more than a standard deviation below its 20-day average of 0.52, suggesting call buyers are outnumbering put buyers at levels not seen over the past year at the low end of the PCR range.

The ownership picture adds one standout detail. Slate Path Capital held 28.4 million shares as of June 30, having added more than 9 million shares in the most recent reporting period. That makes Slate Path the fourth-largest disclosed holder at roughly 5% of shares, behind the passive giants BlackRock, State Street and Vanguard. No 13D activist filings are on the register, and the passive holders' recent changes are all incremental. The insider picture is quieter: recent activity consists entirely of small director stock awards at grant prices of $9.42 to $11.47, and the CFO ran a discretionary sale of $2.9 million in June. Net insider flow over the past 90 days is flat by value. None of this is directionally decisive, but Slate Path's Q2 accumulation at what were lower prices is worth tracking as a sentiment reference point.

Retail attention has spiked sharply. The Wikipedia and ORTEX page-view signal shows a z-score of 4.3 against the prior 90 days as of late September, a level that points to unusually high retail attention around the earnings event. None of the alt-data datasets covering CLF has been measured to lead its reported financials, so this is colour rather than signal, but the spike in attention aligns with the stock's post-earnings move and the surge in analyst activity that followed.

Peers broadly gained on the week: RS added 3.3%, NUE rose 3.0%, and WS climbed 5.2%. CLF's 6.1% weekly gain is respectable in that context, though the 3.2% single-day pullback on October 20 suggests profit-taking arrived quickly after the initial surge. The next earnings event is scheduled for January 25, 2027, leaving roughly 96 days for the debate between Tanners at $17 and Barclays at $11 to play out. With short sellers rebuilding positions into a tightening cost-to-borrow environment and the consensus target barely above the current price, how management frames steel demand conditions and the POSCO partnership timeline in the weeks ahead will likely determine which side of that range the stock tests first.